Invesco’s Ligand Pharmaceuticals LGND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$26.1M Buy
229,858
+27,030
+13% +$3.07M ﹤0.01% 1311
2025
Q1
$21.3M Buy
202,828
+8,473
+4% +$891K ﹤0.01% 1408
2024
Q4
$20.8M Buy
194,355
+5,627
+3% +$603K ﹤0.01% 1464
2024
Q3
$18.9M Buy
188,728
+15,917
+9% +$1.59M ﹤0.01% 1485
2024
Q2
$14.6M Sell
172,811
-42,284
-20% -$3.56M ﹤0.01% 1588
2024
Q1
$15.7M Buy
215,095
+194
+0.1% +$14.2K ﹤0.01% 1567
2023
Q4
$15.3M Sell
214,901
-3,886
-2% -$278K ﹤0.01% 1558
2023
Q3
$13.1M Sell
218,787
-3,196
-1% -$192K ﹤0.01% 1584
2023
Q2
$16M Sell
221,983
-4,120
-2% -$297K ﹤0.01% 1492
2023
Q1
$16.6M Sell
226,103
-783
-0.3% -$57.6K ﹤0.01% 1446
2022
Q4
$15.2M Sell
226,886
-79,401
-26% -$5.3M ﹤0.01% 1538
2022
Q3
$16.5M Sell
306,287
-44,825
-13% -$2.41M 0.01% 1454
2022
Q2
$19.5M Buy
351,112
+39,223
+13% +$2.18M 0.01% 1388
2022
Q1
$21.9M Sell
311,889
-23,157
-7% -$1.62M 0.01% 1455
2021
Q4
$32.3M Sell
335,046
-99,962
-23% -$9.63M 0.01% 1244
2021
Q3
$37.8M Buy
435,008
+53,996
+14% +$4.69M 0.01% 1171
2021
Q2
$31.2M Buy
381,012
+59,181
+18% +$4.84M 0.01% 1332
2021
Q1
$30.6M Buy
321,831
+11,144
+4% +$1.06M 0.01% 1298
2020
Q4
$19.3M Buy
310,687
+14,802
+5% +$918K 0.01% 1450
2020
Q3
$17.6M Buy
295,885
+45,751
+18% +$2.72M 0.01% 1369
2020
Q2
$17.5M Buy
250,134
+9,210
+4% +$643K 0.01% 1339
2020
Q1
$10.9M Sell
240,924
-78,002
-24% -$3.54M ﹤0.01% 1490
2019
Q4
$20.7M Buy
318,926
+270,943
+565% +$17.6M 0.01% 1411
2019
Q3
$2.98M Sell
47,983
-540,339
-92% -$33.6M ﹤0.01% 2409
2019
Q2
$41.9M Buy
588,322
+521,413
+779% +$37.1M 0.01% 1095
2019
Q1
$5.25M Sell
66,909
-136,948
-67% -$10.7M ﹤0.01% 1975
2018
Q4
$17.3M Sell
203,857
-505,560
-71% -$42.8M 0.01% 1213
2018
Q3
$121M Buy
709,417
+235,912
+50% +$40.4M 0.04% 503
2018
Q2
$61.2M Buy
473,505
+119,335
+34% +$15.4M 0.02% 755
2018
Q1
$36.5M Buy
354,170
+16,711
+5% +$1.72M 0.01% 883
2017
Q4
$28.8M Buy
337,459
+17,590
+5% +$1.5M 0.01% 1011
2017
Q3
$27.2M Sell
319,869
-28,812
-8% -$2.45M 0.01% 1045
2017
Q2
$26.4M Sell
348,681
-222,925
-39% -$16.9M 0.01% 1066
2017
Q1
$37.7M Sell
571,606
-89,135
-13% -$5.89M 0.01% 917
2016
Q4
$41.9M Sell
660,741
-135,145
-17% -$8.57M 0.01% 870
2016
Q3
$50.7M Buy
795,886
+39,089
+5% +$2.49M 0.02% 750
2016
Q2
$56.3M Sell
756,797
-159,332
-17% -$11.9M 0.02% 705
2016
Q1
$61.2M Sell
916,129
-270,213
-23% -$18.1M 0.02% 647
2015
Q4
$80.2M Sell
1,186,342
-271,083
-19% -$18.3M 0.03% 590
2015
Q3
$77.9M Sell
1,457,425
-60,648
-4% -$3.24M 0.03% 573
2015
Q2
$95.6M Sell
1,518,073
-330,271
-18% -$20.8M 0.04% 531
2015
Q1
$88.9M Buy
1,848,344
+390,541
+27% +$18.8M 0.03% 554
2014
Q4
$48.4M Buy
1,457,803
+175,331
+14% +$5.82M 0.02% 812
2014
Q3
$37.6M Buy
1,282,472
+408,651
+47% +$12M 0.02% 928
2014
Q2
$34M Sell
873,821
-154,980
-15% -$6.02M 0.01% 994
2014
Q1
$43.2M Buy
1,028,801
+172,857
+20% +$7.25M 0.02% 854
2013
Q4
$28.1M Buy
855,944
+77,360
+10% +$2.54M 0.01% 1073
2013
Q3
$21M Sell
778,584
-156,813
-17% -$4.23M 0.01% 1140
2013
Q2
$21.8M Buy
+935,397
New +$21.8M 0.01% 1069